OTC?
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
378
NCT04890106
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma
Phase: Phase 3
Role: Lead Sponsor
Start: Oct 2, 2021
Completion: Aug 11, 2022
NCT07098663
Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes
Phase: Phase 2
Start: Aug 12, 2025
Completion: Apr 17, 2026
Loading map...